- Home
- OFLX vs ARCT Comparison
OFLX vs ARCT Comparison
Compare OFLX & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OFLX | ARCT |
|---|---|---|
| Founded | 1975 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 266.9M | 293.9M |
| IPO Year | 2005 | 2019 |
Fundamental Metrics
Financial Performance| Metric | OFLX | ARCT |
|---|---|---|
| Price | $25.96 | $10.67 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $23.80 |
| AVG Volume (30 Days) | 39.0K | ★ 643.5K |
| Earning Date | 10-28-2026 | 11-05-2026 |
| Dividend Yield | ★ 5.13% | N/A |
| EPS Growth | N/A | ★ 20.00 |
| EPS | ★ 0.70 | N/A |
| Revenue | ★ $98,296,000.00 | $82,031,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $54.47 |
| P/E Ratio | $37.74 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $23.99 | $5.50 |
| 52 Week High | $37.92 | $17.96 |
Technical Indicators
Market Signals| Indicator | OFLX | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 56.04 | 38.11 |
| Support Level | $24.67 | $6.53 |
| Resistance Level | $26.97 | $9.58 |
| Average True Range (ATR) | 0.95 | 0.99 |
| MACD | 0.23 | -0.07 |
| Stochastic Oscillator | 67.29 | 12.52 |
Price Performance
Historical ComparisonAbout OFLX Omega Flex Inc.
Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States. The company derives revenues from the manufacture and sale of flexible metal hose and accessories.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.